The Medicines and Healthcare Products Regulatory Agency said some packs had been incorrectly labelled and this could lead to patients taking more than advised.
The Medicines and Healthcare Products Regulatory Agency (MHRA) has ruled that warnings about the risk should now be added to drugs like Ozempic, Wegovy and Mounjaro.